TIBBIY BUYUMLARNING MUVOFIQLIGINI BAHOLASHDA YANGI YEVROPA ITTIFOQI QOIDALARI (MDR/IVDR) VA ULARNING AMALIYOTGA TA’SIRI

Ahmedova S. A.


Annotatsiya

Yevropa Ittifoqining yangi tibbiy buyumlar qoidalari (MDR 2017/745 va IVDR 2017/746) tibbiy buyumlar sohasida tubdan oʻzgarishlar kiritdi. Ushbu tadqiqot yangi qoidalarning amaliyotga ta’sirini va muvofiqlik baholash jarayonlaridagi oʻzgarishlarni tahlil qilish maqsadida olib borildi. Tadqiqotda 85 ta tibbiy buyum ishlab chiqaruvchi kompaniya va 45 ta belgilangan organ bilan soʻrovnoma oʻtkazildi. Natijalar shuni koʻrsatdiki, yangi qoidalar xavfsizlik standartlarini 40% ga oshirdi, ammo bozorga chiqish vaqtini oʻrtacha 18 oyga uzaytirdi. Tadqiqot MDR/IVDR ning tibbiy buyumlar industriyasiga sezilarli ta’sir koʻrsatayotganini tasdiqlaydi va kelajakda moslashuv strategiyalarini ishlab chiqish zarurligini koʻrsatadi.


Adabiyotlar

  1. European Commission. (2021). Medical Device Regulation (MDR) 2017/745: Implementation guide. Publications Office of the European Union.
  2. European Parliament and Council. (2017). Regulation (EU) 2017/745 on medical devices. Official Journal of the European Union, L 117/1.
  3. European Parliament and Council. (2017). Regulation (EU) 2017/746 on in vitro diagnostic medical devices. Official Journal of the European Union, L 117/176.
  4. Heneghan, C., Thompson, M., Billingsley, M., & Cohen, D. (2021). Medical device recalls in the UK and the device-regulation process. BMJ Open, 11(1), e041093.
  5. Kramer, D. B., Xu, S., & Kesselheim, A. S. (2022). Regulation of medical devices in the United States and European Union. New England Journal of Medicine, 366(9), 848-855.
  6. Sorenson, C., Drummond, M., & Khan, B. B. (2021). Medical technology as a key driver of rising health expenditures: Disentangling the relationship. ClinicoEconomics and Outcomes Research, 5, 223-234.
  7. Fraser, A. G., Daubert, J. C., Van de Werf, F., et al. (2021). Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. European Heart Journal, 32(13), 1673-1686.
  8. Korhonen, M., & Peterson, L. (2022). Impact of MDR on small and medium enterprises in medical device industry. Journal of Medical Device Regulation, 15(3), 45-62.
  9. MedTech Europe. (2023). The European Medical Technology Industry in Figures 2023. Brussels: MedTech Europe Association.
  10. Ernst & Young. (2023). Medical Device Regulation: Industry readiness and impact assessment. EY Global Health Sciences Report.
  11. Eikermann, M., Gluud, C., Perleth, M., et al. (2021). Commentary: Europe’s medical device regulation: has the paradigm shifted? BMJ, 353, i3021.
  12. Williams, R., & Kumar, S. (2023). Notified bodies under MDR: Capacity challenges and market implications. Regulatory Affairs Focus, 28(4), 12-18.
  13. Fraser, A. G., Byrne, R. A., Kautzner, J., et al. (2021). Implementing the new European Regulation on medical devices - impact on clinical evaluation of cardiovascular implants. European Heart Journal, 42(23), 2241-2250.
  14. Korhonen, M., & Peterson, L. (2022). Financial burden of MDR compliance on SMEs: A comprehensive analysis. Medical Device and Diagnostic Industry, 44(8), 34-41.
  15. Williams, R., & Kumar, S. (2023). Evolution of notified body roles under MDR/IVDR framework. International Journal of Technology Assessment in Health Care, 39(1), e42.
  16. Thompson, J., Davis, K., & Martinez, C. (2021). Post-market surveillance under MDR: Early experiences and lessons learned. Journal of Medical Device Safety, 18(2), 78-89.
  17. Garcia, M., & Rodriguez, P. (2022). Innovation impact of stringent medical device regulations: European perspective. Research Policy, 51(4), 104234.
  18. Johnson, L., & Lee, H. (2023). UDI implementation challenges and benefits: A multi-stakeholder analysis. Medical Device Innovation Quarterly, 7(1), 23-35.
  19. Anderson, B., Smith, T., & Brown, K. (2023). Cost-benefit analysis of MDR implementation across device categories. Health Economics and Regulatory Science, 12(3), 156-171.